Pharmacy

 

“For sale” Fresenius creates new $2.4bn business

As Germany-based healthcare conglomerate Fresenius looks to simplify the group's structure, selling off non-core parts of a business which currently spans hospitals, dialysis, pharma, rehabilitation and more, it is building a $2.4bn new business partnership in the US. We speak to an EU-based source familiar with Fresenius to put this all in context.
March 24, 2022

Stanley Capital acquires DSS

Stanley Capital, the London-based private equity fund, is to buy Drug Safety and Pharmacovigilance Services Solutions ("DSS") from Clario, a global clinical trials player. "DDS" specializes in pharmacovigilance - the assessment and monitoring of interactions between drugs and their effects on the human body. HBI talks to Simon Cottle, the founding partner at Stanley Capital.
February 3, 2022

Bain and CVC ‘buying Boots’

Buyout firms Bain Capital and CVC are reportedly joining forces to put in a multibillion pound bid for UK pharmacy, health and beauty retailer Boots, which also has a presence in Thailand, Norway, Republic of Ireland, Netherlands, Malta and Indonesia.
January 13, 2022

McKesson sells UK arm to turnaround specialist as it exits Europe

US-based pharmacy group McKesson has sold its UK arm - made up of retail pharmacy group Lloyds Pharmacy and a drug distribution business - to Aurelius, an investor specialised in turnarounds. The new owner is likely to focus on the rationalisation of the business, HBI hears.
November 4, 2021

Apollo’s $3.2bn pharmacy arm selling stake after spin off

Apollo Hospitals, India's largest hospital group by revenue, has spun off its pharmacy and digital business into a new subsidiary and appointed banks to sell a 15-20% stake. Amazon was considering a $100m stake in the division at the end of last year as India's online pharmacy sector continues to see a glut of investment with rival PharmEasy also targeting a $9bn IPO.
August 26, 2021

How the world’s largest consumer PE house views healthcare

At HBI 2020 we interviewed Chinta Bhagat, a managing partner at private equity house L Catterton, the world’s biggest private equity investor in consumer products and retail, about the destruction of the general hospital and the new digital models that will replace it. “If you don’t have digital embedded in everything you do in such a way as to give the customer a choice of how to interact with you, your business will eventually be destroyed,” he says. Bhagat should know, he led McKinsey’s healthcare practice in Asia for many years and at Khazanah Nasional was intimately involved in the creation of Pan-Asian hospital chain IHH. He is now scouting the world for digital healthcare investment opportunities.
January 12, 2021

Deploying new generation apps – 6 things health care operators must get right, and the 13 mistakes they often make

New tech promises to allow humans AI-driven health care conversations over text, voice, and email, leading to real dialogue and much more intelligent monitoring. Some of this stuff is here now.  Here are the six main cornerstones health care operators should know when deploying it, and the 13 big mistakes that affect health care operators when they try and do tech stuff.
October 8, 2020

Interview: Nasser Al Hagbani, CEO, Dr. Sulaiman Al Habib Medical Services Group

Saudi/UAE hospital operator Dr. Sulaiman Al Habib Medical Services Group (HmG) is by far the largest player by revenue in the GCC at $1.3bn. Shares have all but doubled since its IPO in March, making it the sixth-largest hospital stock globally by market capitalisation at $8.5bn. Its lucrative tele-ICU centre is the largest in the world by beds monitored. In this exclusive interview, Hagbani discusses HmG's listing, business model, Saudisation efforts, declining expat market and of course COVID-19.
September 2, 2020
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us